No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

被引：1
|
作者：
Wagner, John E. [1 ]
Eapen, Mary [2 ]
Carter, Shelly L. [3 ]
Haut, Paul R. [4 ]
Peres, Edward [5 ]
Schultz, Kirk R. [6 ]
Thompson, Jason [3 ]
Wall, Donna A. [7 ]
Kurtzberg, Joanne [8 ]
机构：
[1] Univ Minnesota, Med Ctr, Pediat Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] EMMES Corp, Rockville, MD USA
[4] Indiana Univ, Dept Pediat, Div Hematol Oncol, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] Duke Univ, Med Ctr, Durham, NC USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.359.359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
359
引用
收藏
页数：2
相关论文
共 50 条
  • [31] DEVELOPMENT AND MANAGEMENT OF A MULTI-CENTER, CENTER-SPECIFIC CELLULAR THERAPY MANUFACTURING APPROACH: THE EXPERIENCE OF THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL #1401
    Nelson, C. L.
    O'Brien, K.
    Mendizabal, A.
    Gersten, I.
    Uhl, L.
    Chung, D.
    Shah, N.
    Avigan, D.
    Pasquini, M.
    CYTOTHERAPY, 2017, 19 (05) : S84 - S84
  • [32] Angiogenic Factors, Inflammation, and Outcomes in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Biomarker Analysis of Gvhd Prophylaxis in Blood and Marrow Transplant Clinical Trials Network Protocol (BMT CTN) 0402
    Newell, Laura F.
    Verneris, Michael R.
    Panoskaltsis-Mortari, Angela
    Defor, Todd E.
    Blazar, Bruce R.
    Cutler, Corey S.
    Antin, Joseph H.
    MacMillan, Margaret L.
    Weisdorf, Daniell
    Holtan, Shernan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S70 - S71
  • [33] Translation of a single-center cellular therapy manufacturing approach to a multi-center, center-specific manufacturing platform: the experience of the blood and marrow transplant clinical trials network (BMT CTN) protocol #1401
    Nelson, Courtney
    O'Brien, Kelly
    Medizabal, Adam
    Gersten, Iris
    Uhl, Lynne
    Chung, David
    Shah, Nina
    Avigan, David
    Pasquini, Marcelo
    TRIALS, 2017, 18
  • [34] Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
    Smith, Eileen P.
    Li, Hongli
    Friedberg, Jonathan W.
    Constine, Louis S.
    Rimsza, Lisa M.
    Cook, James R.
    Laport, Ginna G.
    Popplewell, Leslie L.
    Holmberg, Leona A.
    Smith, Sonali M.
    LeBlanc, Michael
    Forman, Stephen J.
    Fisher, Richard I.
    Stiff, Patrick J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 700 - 707
  • [35] Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303
    Keever-Taylor, Carolyn A.
    Devine, Steven M.
    Soiffer, Robert J.
    Mendizabal, Adam
    Carter, Shelly
    Pasquini, Marcelo C.
    Hari, Parameswaran N.
    Stein, Anthony
    Lazarus, Hillard M.
    Linker, Charles
    Goldstein, Steven C.
    Stadtmauer, Edward A.
    O'Reilly, Richard J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (05) : 690 - 697
  • [36] Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
    Scott, Bart L.
    Pasquini, Marcelo C.
    Logan, Brent
    Wu, Juan
    Devine, Steve
    Porter, David L.
    Maziarz, Richard T.
    Warlick, Erica
    Fernandez, Hugo F.
    Alyea, Edwin P.
    Hamadani, Mehdi
    Bashey, Asad
    Giralt, Sergio A.
    Leifer, Eric
    Geller, Nancy
    Le-Rademacher, Jennifer
    Mendizabal, Adam M.
    Horowitz, Mary M.
    Deeg, H. Joachim
    Horwitz, Mitchell E.
    BLOOD, 2015, 126 (23)
  • [37] Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Anderlini, Paolo
    Wu, Juan
    Deeg, H. Joachim
    Gersten, Iris
    Ewell, Marian
    Tolar, Jakub
    Antin, Joseph H.
    Arai, Sally
    Horwitz, Mitchell E.
    McCarty, John M.
    Nakamura, Ryotaro
    Pulsipher, Michael A.
    Adams, Roberta H.
    Leifer, Eric
    Carter, Shelly L.
    DiFronzo, Nancy L.
    Horowitz, Mary M.
    Confer, Dennis L.
    Eapen, Mary
    BLOOD, 2014, 124 (21)
  • [38] Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) Trial
    Alvarnas, J.
    Le Rademacher, J.
    Wang, Y.
    Little, Richard F.
    Akpek, G.
    Ayala, E.
    Devine, S.
    Kaplan, L.
    Noy, A.
    Popat, U.
    Thompson, J.
    Horowitz, M. H.
    Mendizabal, A.
    Navarro, W. H.
    Ambinder, R.
    BLOOD, 2014, 124 (21)
  • [39] Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients With Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 13 - 14
  • [40] Evaluation of Tumor Vaccine Generation in a Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant (AutoHCT)Followed By Lenalidomide Maintenance for Multiple Myeloma (MM) with or without Vaccination with Dendritic Cell/ Myeloma Fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401
    Avigan, David E.
    Shah, Nina
    Logan, Brent
    Zhu, Jiaxi
    Bisharat, Lina
    Callander, Natalie S.
    Chodon, Thinle
    Dhakal, Binod
    Efebera, Yvonne A.
    Geller, Nancy
    Hematti, Peiman
    Herman, Michele
    Lazarus, Hillard M.
    McKenna, David H., Jr.
    Nelson, Courtney
    Nooka, Ajay
    O'Brien, Kelly
    O'Donnell, Lynn C.
    Rapoport, Aaron P.
    Rosenblatt, Jacalyn
    Soiffer, Robert J.
    Stroopinsky, Dina
    Torka, Pallawi
    Uhl, Lynne
    Waller, Edmund K.
    Wu, Juan
    Young, James W.
    Pasquini, Marcelo C.
    Chung, David J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S62 - S63
12345